LPS challenge

OTHER2 trials

Sponsors

Fraunhofer-Institute of Toxicology and Experimental Medicine, Cambridge University Hospitals NHS Foundation Trust

Conditions

HealthyLung InflammationSarcoidosis

Unknown Phase

Development of Novel Non-invasive Inflammometry Following Lipopolysaccharide, Endotoxin (LPS) Challenge in Healthy Volunteers

CompletedNCT03044327

Fraunhofer-Institute of Toxicology and Experimental MedicineHealthy

Start: 2017-02-15End: 2017-12-31Updated: 2018-05-30

Validation of the Analysis Methodology Behind the Use of Quantitative 18F-FDG PET/CT to Assess Lung Inflammation

Cambridge University Hospitals NHS Foundation TrustLung Inflammation, Sarcoidosis

Start: 2018-01-23End: 2022-01-31Target: 36Updated: 2020-01-09

Related Papers

Exhaled breath particles as a novel tool to study lipid composition of epithelial lining fluid from the distal lung.

2023-11-037 citations

Inflammatory cytokines can be monitored in exhaled breath particles following segmental and inhalation endotoxin challenge in healthy volunteers

Scientific Reports2022-04-048 citations